Novanta (NOVT)

• Market cap: $4.12B
• 1 day: -2.92%
• 5 days: -1.42%
• 1 month: -5.5%
• 3 months: -9.16%
• 6 months: -15.14%
• Year to date: -24.12%
• 1 year: -31.99%
• 5 years: 16.25%
• 10 years: 665.06%
• Sector: Technology
• Industry: Scientific & Technical Instruments

About: Novanta Inc manufactures photonic and motion-control components for original equipment manufacturers in the medical equipment and industrial technology markets. The firm operates in two segments: Automation Enabling Technologies and Medical Solutions. It generates the majority of its revenue from the Medical Solutions segment that designs, manufactures, and markets a range of medical-grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; and wireless technologies. The firm generates the majority of its revenue from the United States and Europe.

Employees: 3,000

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

34% more repeat investments, than reductions

Existing positions increased: 135 | Existing positions reduced: 101

5% more first-time investments, than exits

New positions opened: 45 | Existing positions closed: 43

1% more capital invested

Capital invested by funds: $4.52B [Q1] → $4.56B (+$37.7M) [Q2]

0.07% less ownership

Funds ownership: 98.25% [Q1] → 98.17% (-0.07%) [Q2]

0% less funds holding

Funds holding: 322 [Q1] → 321 (-1) [Q2]

90% less call options, than puts

Call options by funds: $247K | Put options by funds: $2.59M

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $133
• Avg. target: $133
• High target: $133

1 analyst rating

• positive: 0 0%
• neutral: 1 100%
• negative: 0 0%

Baird Robert Mason

$133

Neutral Maintained

11 Aug 2025